| __timestamp | CRISPR Therapeutics AG | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 79838000 |
| Thursday, January 1, 2015 | 12573000 | 121816000 |
| Friday, January 1, 2016 | 42238000 | 117633000 |
| Sunday, January 1, 2017 | 69800000 | 117456000 |
| Monday, January 1, 2018 | 113773000 | 171984000 |
| Tuesday, January 1, 2019 | 179362000 | 257452000 |
| Wednesday, January 1, 2020 | 266946000 | 477643000 |
| Friday, January 1, 2021 | 438633000 | 540684000 |
| Saturday, January 1, 2022 | 461645000 | 651496000 |
| Sunday, January 1, 2023 | 387332000 | 666563000 |
| Monday, January 1, 2024 | 320653000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. CRISPR Therapeutics AG and PTC Therapeutics, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. Since 2014, PTC Therapeutics has consistently outpaced CRISPR Therapeutics in R&D spending, with a notable 50% higher investment on average. By 2023, PTC Therapeutics' R&D expenses surged to nearly 667 million, marking a 735% increase from 2014. Meanwhile, CRISPR Therapeutics also demonstrated a robust growth trajectory, with a 25,500% increase in R&D spending over the same period, reaching approximately 387 million in 2023. This relentless pursuit of innovation underscores the dynamic nature of the biotech industry, where strategic investments in R&D can lead to groundbreaking advancements and sustained competitive advantage.
Research and Development Investment: Zoetis Inc. vs PTC Therapeutics, Inc.
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
United Therapeutics Corporation or PTC Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and PTC Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and CRISPR Therapeutics AG
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CRISPR Therapeutics AG and Evotec SE
PTC Therapeutics, Inc. vs Veracyte, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Evotec SE